Cysteamine: all 26 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired PneumoniaRecruitingNCT02735707Phase 3
- A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis ExacerbationsCompletedNCT03000348Phase 2Results posted
- A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial DiseaseTerminatedNCT02473445Phase 2Results posted
- Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial DiseaseCompletedNCT02023866Phase 2Results posted
- Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With CystinosisCompletedNCT01744782Phase 3Results posted
- Open-Label, Safety and Superior Effectiveness Study of Cysteamine Bitartrate Delayed-Release Capsules (RP103) in CystinosisCompletedNCT01733316Phase 3Results posted
- Study in Healthy Adults to Determine the Effect That Food Has on the Absorption and Delivery of the Drug Cystagon™CompletedNCT01432561Not applicableResults posted
- Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103)CompletedNCT01197378Phase 3Results posted
- An Open Trial of Cysteamine Treatment in SchizophreniaTerminatedNCT01139125Not applicableResults posted
- Phase 3 Study of Cysteamine Bitartrate Delayed-release (RP103) Compared to Cystagon® in Patients With CystinosisCompletedNCT01000961Phase 3Results posted
- Pilot Study of Safety, Tolerability, Pharmacokinetics/Pharmacodynamics of RP103 Compared to Cystagon® in Patients With CystinosisCompletedNCT00872729Phase 1/2Results posted
- A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH)CompletedNCT00799578Phase 1/2Results posted
- Cysteamine Therapy for Major Depressive DisorderTerminatedNCT00715559Not applicableResults posted
- Cystagon to Treat Infantile Neuronal Ceroid LipofuscinosisCompletedNCT00028262Phase 4Results posted
- Cysteamine Eye Drops to Treat Corneal Crystals in CystinosisCompletedNCT00001213Phase 2Results posted
- Effectiveness of a Bilayering Serum and Cream Containing GABA, DMAE, Cysteamine, and Bakuchiol for Skin Whitening and Anti-AgingCompletedNCT07477288Phase 2
- Cysteamine Compared to Hydroquinone in MelasmaCompletedNCT05969587Phase 3
- Efficacy and Safety of Topical Cysteamine for Postinflammatory HyperpigmentationStatus unknownNCT05206318Not applicable
- Cystadrops in Pediatric Cystinosis Patients From Six Months to Less Than Two Years Old (SCOB2)CompletedNCT04125927Phase 3
- Cysteamine for AsthmaCompletedNCT03883984Phase 1
- Efficacy of Topical Cysteamine in Nephropathic CyctinosisCompletedNCT02766855Not applicable
- First Study of Oral Cysteamine in Cystic FibrosisCompletedNCT02212431Phase 1/2
- Multicentric Trial of the Treatment of Huntington's Disease by Cysteamine (RP103)Status unknownNCT02101957Phase 2/3
- Randomized Study of New Formulation Ophthalmic Cysteamine Hydrochloride for Corneal Cystine Accumulation in Patients With CystinosisCompletedNCT00010426Not applicable
- A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV DiseaseCompletedNCT00002110Phase 2
- New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in CystinosisCompletedNCT00001736Phase 1